Top Wall Street Forecasters Revamp Abbott Expectations Ahead Of Q1 Earnings

All NewsApril 14, 2026

Abbott Laboratories (NYSE: ABT) to report Q1 earnings on April 16, expected EPS of $1.15 and revenue of $11B. Acquired Exact Sciences, stock up 0.4%.

Latest Ratings for ABT

DateFirmActionFromTo Jan 2022Morgan StanleyMaintainsOverweight Jan 2022Raymond JamesMaintainsOutperform Jan 2022Morgan StanleyMaintainsOverweight

View More Analyst Ratings for ABT

View the Latest Analyst Ratings

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent